In the first of the Question Time discussions on day two of the Cosmetics Business Regulatory Summit, Jack Ferguson of Skinnovation fielded queries about claims and what has to be considered to comply. The first question was a long and multi-level one: The US does not permit claims that refer to collagen and elastin because they are considered structural claims and therefore drugs; whereas in the EU claims such as ‘boosts collagen’ and ‘promotes elastin’ are widely used. Can these be substantiated under the Common Criteria for Claims, and would the Advertising Standards Authority in the UK accept that data can be provided to support their use on cosmetic products? And how much can ingredient information be used to support product attributes?
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.